Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 3 (43%) |
| No statute on record | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOWARD, ZACHARY C | 1 | 63.9% | +38.2% |
| RZECZYCKI, PHILLIP MATTHEW | 1 | 57.4% | +45.0% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.8% | +28.3% |
| YAO, LEI | 1 | 60.0% | +65.6% |
| ELENISTE, PIERRE PAUL | 1 | 38.5% | +30.2% |
| BRAUN, MADELINE E | 1 | 68.0% | +24.9% |
| SCHMITT, MICHAEL J | 1 | 56.6% | +21.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17617479 | 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS | ELENISTE, PIERRE PAUL | 140d overdue |
| 18256982 | Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 Inhibitors | SEITZ, ANTHONY JOSEPH | 79d overdue |
| 17600660 | GEPOTIDACIN FOR USE IN THE TREATMENT OF BACTERIAL URINARY TRACT INFECTIONS | BRAUN, MADELINE E | 8d overdue |
| 18613481 | METHODS OF TREATING AN IL-5 MEDIATED DISEASE BY ADMINISTERING AN IL-5 BINDING PROTEIN | HOWARD, ZACHARY C | 7d |
| 17412070 | NON PEPTIDIC HETEROBIVALENT MOLECULES FOR TREATING INFLAMMATORY DISEASES | SCHMITT, MICHAEL J | 29d |
| 18569648 | Pharmaceutical Compound | RZECZYCKI, PHILLIP MATTHEW | 53d |
| 17950667 | CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN-3 AND METHODS FOR TREATING CANCER | YAO, LEI | 78d |
| Art Unit | Apps |
|---|---|
| 1629 | 2 |
| 1674 | 1 |
| 1625 | 1 |
| 1642 | 1 |
| 1622 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18613481 | METHODS OF TREATING AN IL-5 MEDIATED DISEASE BY ADMINISTERING AN IL-5 BINDING PROTEIN | HOWARD, ZACHARY C | 1674 | — | Non-Final OA | 7d | Pending | Mar 22, 2024 |
| 18569648 | Pharmaceutical Compound | RZECZYCKI, PHILLIP MATTHEW | 1625 | §112 | Non-Final OA | 53d | Pending | Dec 13, 2023 |
| 18256982 | Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 Inhibitors | SEITZ, ANTHONY JOSEPH | 1629 | Other | Non-Final OA | 79d overdue | Pending | Jun 12, 2023 |
| 17950667 | CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN-3 AND METHODS FOR TREATING CANCER | YAO, LEI | 1642 | §112 | Non-Final OA | 78d | Pending | Sep 22, 2022 |
| 17617479 | 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS | ELENISTE, PIERRE PAUL | 1622 | §112 | Final Rejection | 140d overdue | Pending | Dec 08, 2021 |
| 17600660 | GEPOTIDACIN FOR USE IN THE TREATMENT OF BACTERIAL URINARY TRACT INFECTIONS | BRAUN, MADELINE E | 1624 | Other | Non-Final OA | 8d overdue | Pending | Oct 01, 2021 |
| 17412070 | NON PEPTIDIC HETEROBIVALENT MOLECULES FOR TREATING INFLAMMATORY DISEASES | SCHMITT, MICHAEL J | 1629 | Other | Final Rejection | 29d | Pending | Aug 25, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial